Ascendis Pharma A/S reports results for the quarter ended in March - Earnings Summary

Ascendis Pharma A/S

27/05/2021 22:02

* Ascendis Pharma A/S  ASND.OQ  reported a quarterly adjusted
loss of €1.17​​ per share for the quarter ended in March. The
mean expectation of nine analysts for the quarter was for a loss
of €1.71 per share.
* Revenue fell 66.5% to €746.00 thousand from a year ago; 
analysts expected €1.88 million. 
* Ascendis Pharma A/S's reported EPS for the quarter was a loss
of €1.17​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ascendis Pharma A/S shares had risen by 3.8% this quarter and
lost 19.8% so far this year.
* The company reported a quarterly loss of €62.79 million.
* Wall Street's median 12-month price target for Ascendis Pharma
A/S is $190.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 27 at 09:02 p.m. GMT.
​All figures in euros